Sage Therapeutics (SAGE) announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the ...

Sage Therapeutics Inc. pushed off questions about ... transaction or other strategic outcome,” Barry Greene, Sage’s CEO, said on Tuesday on the company's earnings call.

Sage Therapeutics has said it will cut its headcount ... to launch Zurzuvae and help women suffering with PPD," said Sage's CEO, Barry Greene . "Executing on launch and our potential long ...

Sage Therapeutics CEO Barry Greene expressed his gratitude for her contributions, particularly highlighting her advocacy for maternal mental health. Mike Quirk, the current Chief Scientific ...

New leadership at Seattle-area companies including Starbucks, Avanade, Tune Therapeutics, Umoja Biopharma, Siteimprove and ...

Throughout the last three months, 7 analysts have evaluated Sage Therapeutics (NASDAQ:SAGE), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of ...

Sage Therapeutics Inc (NASDAQ ... the sales force expansion and marketing efforts for ZURZUVAE? A: Barry Greene, CEO, explained that based on 2024's performance, Sage and Biogen have aligned ...

Despite challenging market conditions, the stock has shown resilience with a 32.6% year-to-date return. Sage Therapeutics CEO Barry Greene expressed his gratitude for her contributions, particularly ...